Team Taylor
Taylor Community President & CEO Michael Flaherty discusses his experience growing the continuing care retirement community to three campuses in the Lakes Region ... and more
Bentley gets Europe OKs
Bentley Pharmaceuticals announced Monday that its European subsidiaries have received a dozen approvals to market a number of generic drugs used to combat depression, cholesterol and enlarged prostate glands.
The Exeter-based firm said its approval to market Citalopram, the generic version of the antidepressant drug Celexa, may be particularly lucrative. The market size for that class of drugs is approximately $540 million, of which Citalopram accounts for $48.7 million, an 8 percent growth over the past year.
The company also received approval to market Finasteride, used to treat prostrate glands, and Pravastatin, a cholesterol-reducing agent.
The Exeter-based drug company said that that brings to 51 the total of 51 European approvals received over the past 12 months, 21 of which were in Spain. – BOB SANDERS
